Table 2.
Men |
Women |
Overall |
||||
---|---|---|---|---|---|---|
AL (n = 22) | CR (n = 44) | AL (n = 53) | CR (n = 99) | AL (n = 75) | CR (n = 143) | |
ALT (IU/L) | 26 (12) | 24 (9) | 15 (5) | 16 (6) | 18 (9) | 18 (8) |
AST (IU/L) | 22 (6) | 22 (5) | 19 (4) | 19 (6) | 20 (5) | 20 (5) |
ALP (IU/L) | 70 (16) | 65 (16) | 58 (15) | 57 (18) | 62 (16) | 59 (18) |
GGT (IU/L) | 27 (19) | 24 (13) | 14 (6) | 16 (11) | 18 (13) | 18 (12) |
Bilirubin (mg/dL) | 0.71 (0.46) | 0.62 (0.30) | 0.59 (0.42) | 0.48 (0.23) | 0.63 (0.43) | 0.52 (0.26) |
Abbreviations: AL, ad libitum; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CR, calorie restriction; GGT, gamma-glutamyl transferase.
Values are mean (± SD).
Wilcoxon rank sum test revealed significant differences between men and women for all biomarkers (P < 0.01), but no significant differences between CR and AL groups were observed (P ≥ 0.15).